Doug Ellison

Doug Ellison has a diverse work experience in the medical industry. Doug most recently worked as the Chief Revenue Officer at MicroTransponder, where they played a key role in the development of the Paired VNS platform, aimed at improving the quality of life for patients with chronic neurological conditions. Doug was also involved in the Vivistim System, which helps stroke patients regain arm and hand motor function.

Before that, Doug was the Director of Hybrid Therapies - LARIAT at AtriCure, Inc. from 2019 to 2022. Prior to AtriCure, they served as the VP of Sales and Marketing at SentreHEART, which was later acquired by AtriCure.

Doug's experience also includes roles as VP of Sales and Marketing at Cardica Inc., VP of Sales at Artemis Medical (acquired by JNJ), Director - West at Heartport (acquired by JNJ), Southwest Director at Guidant, and Western Area Manager at Davol Inc. (a division of C.R. Bard).

Overall, Doug has a strong background in sales, marketing, and leadership within the medical field, particularly in the areas of cardiac and neurological therapies.

Doug Ellison studied engineering at Purdue University from 1981 to 1985, earning a Bachelor of Science in Civil Engineering.